Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
SH3 domain binding protein 2 | 0.623 | 0.654 | 1.2E-11 |
|
disease | 1.000 | None | 0.971 | 0 | 4 | 2001 | 2019 | ||||||||
|
Fas cell surface death receptor | 0.372 | 0.923 | 0.81 |
|
disease | 1.000 | strong | 1.000 | 0 | 2 | 1978 | 2018 | ||||||||
|
coproporphyrinogen oxidase | 0.488 | 0.846 | 0.17 |
|
disease | 1.000 | strong | 0.938 | 0 | 1 | 1983 | 2019 | ||||||||
|
paired box 6 | 0.450 | 0.769 | 1.00 |
|
disease | 1.000 | strong | 0.938 | 0 | 0 | 1983 | 2011 | ||||||||
|
uromodulin | 0.520 | 0.846 | 3.1E-17 |
|
disease | 1.000 | None | 1.000 | 0 | 15 | 2001 | 2018 | ||||||||
|
endothelin receptor type B | 0.470 | 0.846 | 9.2E-03 |
|
disease | 1.000 | moderate | 1.000 | 0 | 7 | 1994 | 2018 | ||||||||
|
AT-rich interaction domain 1B | 0.503 | 0.846 | 1.00 |
|
disease | 1.000 | definitive | 1.000 | 0 | 3 | 2012 | 2020 | ||||||||
|
T-box transcription factor 1 | 0.433 | 0.808 | 0.84 |
|
disease | 1.000 | None | 0.988 | 0 | 1 | 1995 | 2019 | ||||||||
|
tripartite motif containing 37 | 0.610 | 0.654 | 9.7E-12 |
|
disease | 1.000 | None | 1.000 | 0 | 13 | 1999 | 2020 | ||||||||
|
collagen type II alpha 1 chain | 0.444 | 0.846 | 1.00 |
|
disease | 1.000 | None | 1.000 | 0 | 11 | 1988 | 2012 | ||||||||
|
neurofibromin 1 | 0.440 | 0.885 | 0.90 |
|
group | 1.000 | strong | 0.941 | 0 | 10 | 1992 | 2019 | ||||||||
|
EBP cholestenol delta-isomerase | 0.494 | 0.846 | 0.94 |
|
disease | 1.000 | strong | 1.000 | 0 | 38 | 1983 | 2019 | ||||||||
|
myelin protein zero | 0.503 | 0.846 | 0.27 |
|
disease | 1.000 | None | 1.000 | 0 | 5 | 1992 | 2019 | ||||||||
|
TIMP metallopeptidase inhibitor 3 | 0.445 | 0.923 | 0.63 |
|
disease | 1.000 | limited | 1.000 | 0 | 5 | 1994 | 2019 | ||||||||
|
gap junction protein alpha 1 | 0.393 | 0.885 | 0.16 |
|
disease | 1.000 | None | 1.000 | 0 | 12 | 1975 | 2019 | ||||||||
|
retinoic acid induced 1 | 0.545 | 0.731 | 1.00 |
|
disease | 1.000 | definitive | 0.981 | 0 | 6 | 2001 | 2019 | ||||||||
|
myotubularin related protein 2 | 0.659 | 0.538 | 3.0E-07 |
|
disease | 1.000 | None | 1.000 | 0 | 5 | 1999 | 2018 | ||||||||
|
glycoprotein Ib platelet subunit alpha | 0.565 | 0.692 | 3.2E-03 |
|
disease | 1.000 | None | 1.000 | 0 | 1 | 1990 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 1.000 | None | 0.985 | 0 | 2 | 2001 | 2020 | ||||||||
|
neurobeachin like 2 | 0.617 | 0.769 | 6.0E-02 |
|
disease | 1.000 | definitive | 0.917 | 0 | 9 | 2010 | 2019 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 1.000 | None | 0.973 | 0 | 9 | 1982 | 2020 | ||||||||
|
zinc finger protein, FOG family member 2 | 0.565 | 0.731 | 1.00 |
|
disease | 1.000 | limited | 0.929 | 0 | 1 | 2000 | 2018 | ||||||||
|
cartilage oligomeric matrix protein | 0.503 | 0.808 | 1.3E-09 |
|
disease | 1.000 | None | 0.974 | 0 | 12 | 1995 | 2019 | ||||||||
|
Fraser extracellular matrix complex subunit 1 | 0.560 | 0.577 | 3.1E-45 |
|
disease | 1.000 | strong | 0.867 | 0 | 2 | 2006 | 2017 | ||||||||
|
transferrin receptor 2 | 0.585 | 0.615 | 1.3E-09 |
|
disease | 1.000 | None | 1.000 | 0 | 15 | 2001 | 2019 |